Methamphetamine Clinical Trials
Each year, 24.7 million people use amphetamine (MA) worldwide, which represents more consumers than individuals who use heroin or cocaine. Despite these numbers, there are currently no FDA-approved medications to treat MA dependence. And while behavioral counseling options can help many, too often it is not enough. UCLA CBAM is one of the leading methamphetamine research groups in the nation and is working to translate the latest scientific discoveries into new and more effective treatments for methamphetamine addiction. New clinical trials are currently under development and expected to launch in 2023. Check the Active Studies section of our Research tab for more details.
Meth Facts and Resources
Methamphetamine is a highly addictive stimulant. It is known by many names including meth, ice, speed, crystal, crank, fire, glass, and tweek. Meth appears as white or yellow crystalline powder or as a large hard rock. It is odorless and has a bitter taste.
Effects of methamphetamine are severe and can include increased heart rate and blood pressure, seizures, stroke, psychosis and death. Short term effects of the drug include nausea, vomiting, convulsions, tremors, anxiety, and paranoia.
Withdrawal symptoms can include stomach cramps, intense hunger, headaches, shortness of breath, exhaustion and severe depression.
For more information, visit the National Institute on Drug Abuse.
Interested in participating in a research study or have questions about counseling, therapy or addiction treatment? Call us at (323) 461-3106 or email us at email@example.com to get more information about research studies of medical treatment for meth addiction or referrals to other programs that may be appropriate for substance addiction. We have also listed a few resources below including links to organizations that serve the LGBTQ community.